SOV Therapeutics, Inc. (SOV) is a privately held clinical stage biotechnology company focused on improving the utility of known efficacious pharmaceutical compounds by employing innovative drug delivery technologies. These technologies are designed to avoid the negative effects of first-pass metabolism by the liver. SOV-developed products seek to deliver medications with reduced side effects and improved patient outcomes compared to existing marketed products.
Looking for a particular SOV Therapeutics employee's phone or email?
The SOV Therapeutics annual revenue was $4 million in 2026.
SOV Therapeutics is based in Morrisville, North Carolina.
The NAICS codes for SOV Therapeutics are [5417, 54, 541, 541714, 54171].
The SIC codes for SOV Therapeutics are [873, 87].